CollPlant Biotechnologies Ltd. (CLGN) NASDAQ

2.56

-0.5299(-17.15%)

Updated at September 30 01:27PM

Currency In USD

Valuation

Market Cap41.24M
Enterprise Value32.41M
P/E Ratio-2.81
PEG Ratio-0.38
Price/Sales Ratio14.86
Price/Book Ratio2.93
Enterprise/Revenue11.24
Enterprise/EBITDA-2.18

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-5.41
Operating Margin-5.55

Management Effectiveness

Return On Assets-0.75
Return On Equity-0.94

Income Statement

Revenue515,000
Revenue/Share0.2
Gross Profit-1.11M
EBITDA-16.21M
Net Income-16.61M
Diluted EPS-1.45

Balance Sheet

Total Cash11.71M
Total Cash/Share0.99
Total Debt3.03M
Total Debt/Equity0.24
Current Ratio4.6
Book Value Per Share1.06

Price History

52-Week Change-37.83
52-Week High5
52-Week Low1.31
Moving Average 50 Days2.59
Moving Average 200 Days2.72

Statistics

Average Volume41,477
Shares Outstanding11.55M
% Held by Institutions0.03

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:3
Last Split DateDecember 01, 2016